10 20 30 40 50 60 70 80 1GWQ - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER NUCLEAR RECEPTOR 22-MAR-02 1GWQ
TITLE HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN TITLE 2 COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: OESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN, RESIDUES 301-548; COMPND 5 SYNONYM: ER, ESTRADIOL RECEPTOR, ER-ALPHA; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: LIGAND-BINDING DOMAIN (DOMAIN E - RESIDUES COMPND 8 260-500) IN COMPLEX WITH THE AGONIST RALOXIFENE CORE; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 2; COMPND 11 CHAIN: C, D; COMPND 12 FRAGMENT: NUCLEAR RECEPTOR BOX II, RESIDUES 688-696; COMPND 13 SYNONYM: TRANSCRIPTION INTERMEDIARY FACTOR-2, TIF2; COMPND 14 OTHER_DETAILS: TIF2 NR-BOX REGION 2 DERIVED PEPTIDE COMPND 15 (RESIDUES 685-696)
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: JM109; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: C1857; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PEALPHA 35; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606
KEYWDS NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, TRANSACTIVATION, KEYWDS 2 AGONIST, AF2 COACTIVATOR , RECEPTOR, ACTIVATOR, KEYWDS 3 TRANSCRIPTI REGULATION, DNA-BINDING, NUCLEAR PROTEIN, ZINC KEYWDS 4 FINGER, STER BINDING, PHOSPHORYLATION, POLYMORPHISM, KEYWDS 5 ALTERNATIVE SPLICIN
EXPDTA X-RAY DIFFRACTION
AUTHOR A.C.W.PIKE,A.M.BRZOZOWSKI
REVDAT 2 24-FEB-09 1GWQ 1 VERSN REVDAT 1 29-AUG-02 1GWQ 0
JRNL AUTH A.WARNMARK,E.TREUTER,J.-A.GUSTAFSSON,R.E.HUBBARD, JRNL AUTH 2 A.M.BRZOZOWSKI,A.C.W.PIKE JRNL TITL INTERACTION OF TRANSCRIPTIONAL INTERMEDIARY FACTOR JRNL TITL 2 2 NUCLEAR RECEPTOR BOX PEPTIDES WITH THE JRNL TITL 3 COACTIVATOR BINDING SITE OF ESTROGEN RECEPTOR JRNL TITL 4 ALPHA. JRNL REF J.BIOL.CHEM. V. 277 21862 2002 JRNL REFN ISSN 0021-9258 JRNL PMID 11937504 JRNL DOI 10.1074/JBC.M200764200
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.M.BRZOZOWSKI,A.C.PIKE,Z.DAUTER,R.E.HUBBARD, REMARK 1 AUTH 2 T.BONN,O.ENGSTROM,L.OHMAN,G.L.GREENE, REMARK 1 AUTH 3 J.A.GUSTAFSSON,M.CARLQUIST REMARK 1 TITL MOLECULAR BASIS OF AGONISM AND ANTAGONISM IN THE REMARK 1 TITL 2 OESTROGEN RECEPTOR REMARK 1 REF NATURE V. 389 753 1997 REMARK 1 REFN ISSN 0028-0836 REMARK 1 PMID 9338790 REMARK 1 DOI 10.1038/39645
REMARK 2 REMARK 2 RESOLUTION. 2.45 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.0 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 17829 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 972 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.45 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.56 REMARK 3 REFLECTION IN BIN (WORKING SET) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2480 REMARK 3 BIN FREE R VALUE SET COUNT : 104 REMARK 3 BIN FREE R VALUE : 0.3430 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4039 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 119 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 42.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 1.000 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.330 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.935 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.897 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): NULL ; NULL ; NULL REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : NULL REMARK 3 ION PROBE RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: SCALING DETAILS BABINET"S PRINCIPLE REMARK 3 FOR SCALING HAS BEEN USED BULK SOLVENT CORRECTION BASED ON REMARK 3 CONSTANT VALUE HAS BEEN USED METHOD USED: BULK SOLVENT REMARK 3 CONTRIBUTIONS CALCULATED BY XPLOR WERE INCORPORATED IN THE REMARK 3 FORM OF PARTIAL STRUCTURE FACTORS
REMARK 4 REMARK 4 1GWQ COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-MAR-02. REMARK 100 THE PDBE ID CODE IS EBI-9298.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-NOV-98 REMARK 200 TEMPERATURE (KELVIN) : 120.0 REMARK 200 PH : 8.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19048 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.450 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.06600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.30200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 8.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1ERE REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 6-11% (W/V) PEG 1500, REMARK 280 4% (V/V) DMF
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 31.81000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 TYR A 331 REMARK 465 ASP A 332 REMARK 465 PRO A 333 REMARK 465 THR A 334 REMARK 465 ARG A 335 REMARK 465 TYR B 331 REMARK 465 ASP B 332 REMARK 465 PRO B 333 REMARK 465 THR B 334 REMARK 465 ARG B 335 REMARK 465 PRO B 336
REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 462 CG CD1 CD2 REMARK 470 ARG A 548 CG CD NE CZ NH1 NH2 REMARK 470 SER B 463 OG REMARK 470 ARG B 548 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 688 CG CD CE NZ REMARK 470 ASP C 696 CG OD1 OD2 REMARK 470 LYS D 688 CG CD CE NZ
REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; REMARK 480 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 480 I=INSERTION CODE): REMARK 480 M RES CSSEQI ATOMS REMARK 480 LYS B 531 CG CD CE NZ REMARK 480 LEU B 541 CG CD1 CD2
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 321 CB - CG - OD1 ANGL. DEV. = 6.7 DEGREES REMARK 500 ARG A 352 NE - CZ - NH1 ANGL. DEV. = 5.1 DEGREES REMARK 500 HIS A 356 CB - CG - ND1 ANGL. DEV. = 9.4 DEGREES REMARK 500 ARG A 394 NE - CZ - NH2 ANGL. DEV. = 5.5 DEGREES REMARK 500 MET A 396 CA - CB - CG ANGL. DEV. = 12.0 DEGREES REMARK 500 CYS A 417 CB - CA - C ANGL. DEV. = -7.7 DEGREES REMARK 500 ARG A 434 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 ARG A 436 CD - NE - CZ ANGL. DEV. = 34.9 DEGREES REMARK 500 ARG A 477 NE - CZ - NH2 ANGL. DEV. = 3.4 DEGREES REMARK 500 ASP A 480 CB - CG - OD1 ANGL. DEV. = 8.2 DEGREES REMARK 500 ASP A 484 CB - CG - OD1 ANGL. DEV. = 6.2 DEGREES REMARK 500 ASP B 321 CB - CG - OD2 ANGL. DEV. = -9.1 DEGREES REMARK 500 PRO B 324 C - N - CA ANGL. DEV. = 9.3 DEGREES REMARK 500 ARG B 352 NE - CZ - NH2 ANGL. DEV. = 5.2 DEGREES REMARK 500 ASP B 374 CB - CG - OD1 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP B 411 CB - CG - OD2 ANGL. DEV. = 6.4 DEGREES REMARK 500 ARG B 412 CD - NE - CZ ANGL. DEV. = 9.5 DEGREES REMARK 500 ARG B 412 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 ARG B 434 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 ARG B 436 CD - NE - CZ ANGL. DEV. = 52.7 DEGREES REMARK 500 ARG B 436 NE - CZ - NH2 ANGL. DEV. = 4.9 DEGREES REMARK 500 VAL B 446 CB - CA - C ANGL. DEV. = 14.2 DEGREES REMARK 500 TYR B 459 CA - CB - CG ANGL. DEV. = -11.9 DEGREES REMARK 500 TYR B 459 CB - CG - CD1 ANGL. DEV. = -5.4 DEGREES REMARK 500 ASP B 480 CB - CG - OD1 ANGL. DEV. = 6.4 DEGREES REMARK 500 ASP B 484 CB - CG - OD1 ANGL. DEV. = 9.6 DEGREES REMARK 500 ARG B 515 NE - CZ - NH1 ANGL. DEV. = 4.4 DEGREES REMARK 500 ARG B 515 NE - CZ - NH2 ANGL. DEV. = -6.9 DEGREES REMARK 500 ARG C 692 NE - CZ - NH1 ANGL. DEV. = 4.6 DEGREES REMARK 500 ARG D 692 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU B 408 74.24 -157.16 REMARK 500 LEU B 462 73.06 49.40 REMARK 500 SER B 463 132.07 -178.06 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZTW A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZTW B 600
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A52 RELATED DB: PDB REMARK 900 ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN REMARK 900 COMPLEXED TO ESTRADIOL REMARK 900 RELATED ID: 1AKF RELATED DB: PDB REMARK 900 HOMOLOGOUS-EXTENSION-BASED MODEL OF HUMAN REMARK 900 ESTROGEN RECEPTOR WITH BOUND ESTRADIOL, REMARK 900 THEORETICAL MODEL REMARK 900 RELATED ID: 1ERE RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN REMARK 900 IN COMPLEX WITH 17BETA-ESTRADIOL REMARK 900 RELATED ID: 1ERR RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN REMARK 900 IN COMPLEX WITH RALOXIFENE REMARK 900 RELATED ID: 1G50 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A WILD TYPE HER ALPHA REMARK 900 LBD AT 2.9ANGSTROM RESOLUTION REMARK 900 RELATED ID: 1GWQ RELATED DB: PDB REMARK 900 HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING REMARK 900 DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND REMARK 900 TIF2 NRBOX2 PEPTIDE REMARK 900 RELATED ID: 1HCP RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: HUMAN/CHICKEN ESTROGEN REMARK 900 RECEPTOR; CHAIN: NULL; DOMAIN: DEOXYRIBONUCLEIC REMARK 900 ACID-BINDING DOMAIN (ERDBD); ENGINEERED: YES REMARK 900 RELATED ID: 1HCQ RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: HUMAN/CHICKEN ESTROGEN REMARK 900 RECEPTOR; CHAIN: A, B, E, F; DOMAIN: REMARK 900 DEOXYRIBONUCLEIC ACID-BINDING DOMAIN (ERDBD); REMARK 900 ENGINEERED: YES; MOL_ID: 2; MOLECULE: REMARK 900 DEOXYRIBONUCLEIC ACID (5'-D( REMARK 900 CPCPAPGPGPTPCPAPCPAPGPTPGP APCPCPTPG)-3') (DOT) REMARK 900 DEOXYRIBONUCLEIC ACID (5'-D(CPCPAPGPGPTPCPA REMARK 900 PCPTPGPTPGPAPCPCPTPG)-3'); CHAIN: C, D, G, H REMARK 900 RELATED ID: 1QKT RELATED DB: PDB REMARK 900 RELATED ID: 1QKU RELATED DB: PDB REMARK 900 RELATED ID: 3ERD RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING REMARK 900 DOMAIN INCOMPLEX WITH DIETHYLSTILBESTROL AND A REMARK 900 GLUCOCORTICOIDRECEPTOR INTERACTING PROTEIN 1 REMARK 900 NR BOX II PEPTIDE REMARK 900 RELATED ID: 3ERT RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING REMARK 900 DOMAIN IN COMPLEX WITH 4-HYDROXYTAMOXIFEN
DBREF 1GWQ A 301 548 UNP P03372 ESR1_HUMAN 301 548 DBREF 1GWQ B 301 548 UNP P03372 ESR1_HUMAN 301 548 DBREF 1GWQ C 688 696 UNP Q15596 NCO2_HUMAN 688 696 DBREF 1GWQ D 688 696 UNP Q15596 NCO2_HUMAN 688 696
SEQRES 1 A 248 SER LYS LYS ASN SER LEU ALA LEU SER LEU THR ALA ASP SEQRES 2 A 248 GLN MET VAL SER ALA LEU LEU ASP ALA GLU PRO PRO ILE SEQRES 3 A 248 LEU TYR SER GLU TYR ASP PRO THR ARG PRO PHE SER GLU SEQRES 4 A 248 ALA SER MET MET GLY LEU LEU THR ASN LEU ALA ASP ARG SEQRES 5 A 248 GLU LEU VAL HIS MET ILE ASN TRP ALA LYS ARG VAL PRO SEQRES 6 A 248 GLY PHE VAL ASP LEU THR LEU HIS ASP GLN VAL HIS LEU SEQRES 7 A 248 LEU GLU CYS ALA TRP LEU GLU ILE LEU MET ILE GLY LEU SEQRES 8 A 248 VAL TRP ARG SER MET GLU HIS PRO GLY LYS LEU LEU PHE SEQRES 9 A 248 ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN GLY LYS CYS SEQRES 10 A 248 VAL GLU GLY MET VAL GLU ILE PHE ASP MET LEU LEU ALA SEQRES 11 A 248 THR SER SER ARG PHE ARG MET MET ASN LEU GLN GLY GLU SEQRES 12 A 248 GLU PHE VAL CYS LEU LYS SER ILE ILE LEU LEU ASN SER SEQRES 13 A 248 GLY VAL TYR THR PHE LEU SER SER THR LEU LYS SER LEU SEQRES 14 A 248 GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE SEQRES 15 A 248 THR ASP THR LEU ILE HIS LEU MET ALA LYS ALA GLY LEU SEQRES 16 A 248 THR LEU GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU SEQRES 17 A 248 LEU ILE LEU SER HIS ILE ARG HIS MET SER ASN LYS GLY SEQRES 18 A 248 MET GLU HIS LEU TYR SER MET LYS CYS LYS ASN VAL VAL SEQRES 19 A 248 PRO LEU TYR ASP LEU LEU LEU GLU MET LEU ASP ALA HIS SEQRES 20 A 248 ARG SEQRES 1 B 248 SER LYS LYS ASN SER LEU ALA LEU SER LEU THR ALA ASP SEQRES 2 B 248 GLN MET VAL SER ALA LEU LEU ASP ALA GLU PRO PRO ILE SEQRES 3 B 248 LEU TYR SER GLU TYR ASP PRO THR ARG PRO PHE SER GLU SEQRES 4 B 248 ALA SER MET MET GLY LEU LEU THR ASN LEU ALA ASP ARG SEQRES 5 B 248 GLU LEU VAL HIS MET ILE ASN TRP ALA LYS ARG VAL PRO SEQRES 6 B 248 GLY PHE VAL ASP LEU THR LEU HIS ASP GLN VAL HIS LEU SEQRES 7 B 248 LEU GLU CYS ALA TRP LEU GLU ILE LEU MET ILE GLY LEU SEQRES 8 B 248 VAL TRP ARG SER MET GLU HIS PRO GLY LYS LEU LEU PHE SEQRES 9 B 248 ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN GLY LYS CYS SEQRES 10 B 248 VAL GLU GLY MET VAL GLU ILE PHE ASP MET LEU LEU ALA SEQRES 11 B 248 THR SER SER ARG PHE ARG MET MET ASN LEU GLN GLY GLU SEQRES 12 B 248 GLU PHE VAL CYS LEU LYS SER ILE ILE LEU LEU ASN SER SEQRES 13 B 248 GLY VAL TYR THR PHE LEU SER SER THR LEU LYS SER LEU SEQRES 14 B 248 GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE SEQRES 15 B 248 THR ASP THR LEU ILE HIS LEU MET ALA LYS ALA GLY LEU SEQRES 16 B 248 THR LEU GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU SEQRES 17 B 248 LEU ILE LEU SER HIS ILE ARG HIS MET SER ASN LYS GLY SEQRES 18 B 248 MET GLU HIS LEU TYR SER MET LYS CYS LYS ASN VAL VAL SEQRES 19 B 248 PRO LEU TYR ASP LEU LEU LEU GLU MET LEU ASP ALA HIS SEQRES 20 B 248 ARG SEQRES 1 C 9 LYS ILE LEU HIS ARG LEU LEU GLN ASP SEQRES 1 D 9 LYS ILE LEU HIS ARG LEU LEU GLN ASP
HET ZTW A 600 17 HET ZTW B 600 17
HETNAM ZTW RALOXIFENE CORE
FORMUL 5 ZTW 2(C14 H10 O2 S) FORMUL 7 HOH *119(H2 O1)
HELIX 1 1 SER A 305 SER A 309 5 5 HELIX 2 2 THR A 311 GLU A 323 1 13 HELIX 3 3 SER A 338 VAL A 364 1 27 HELIX 4 4 GLY A 366 LEU A 370 5 5 HELIX 5 5 THR A 371 MET A 396 1 26 HELIX 6 6 ASN A 413 VAL A 418 5 6 HELIX 7 7 GLY A 420 ASN A 439 1 20 HELIX 8 8 GLN A 441 SER A 456 1 16 HELIX 9 9 THR A 465 ALA A 493 1 29 HELIX 10 10 THR A 496 LYS A 531 1 36 HELIX 11 11 TYR A 537 ALA A 546 1 10 HELIX 12 12 SER B 305 SER B 309 5 5 HELIX 13 13 THR B 311 ALA B 322 1 12 HELIX 14 14 SER B 338 ARG B 363 1 26 HELIX 15 15 GLY B 366 LEU B 370 5 5 HELIX 16 16 THR B 371 MET B 396 1 26 HELIX 17 17 ARG B 412 LYS B 416 1 5 HELIX 18 18 GLY B 420 ASN B 439 1 20 HELIX 19 19 GLN B 441 SER B 456 1 16 HELIX 20 20 GLY B 457 PHE B 461 5 5 HELIX 21 21 THR B 465 ALA B 493 1 29 HELIX 22 22 THR B 496 LYS B 531 1 36 HELIX 23 23 TYR B 537 ARG B 548 1 12 HELIX 24 24 LYS C 688 ASP C 696 1 9 HELIX 25 25 LYS D 688 ASP D 696 1 9
SHEET 1 AA 2 LYS A 401 ALA A 405 0 SHEET 2 AA 2 LEU A 408 ASP A 411 -1 O LEU A 408 N PHE A 404 SHEET 1 BA 2 LYS B 401 ALA B 405 0 SHEET 2 BA 2 LEU B 408 ASP B 411 -1 O LEU B 408 N PHE B 404
SITE 1 AC1 8 LEU A 346 GLU A 353 LEU A 387 ARG A 394 SITE 2 AC1 8 MET A 421 HIS A 524 LEU A 525 HOH A2059 SITE 1 AC2 9 MET B 343 GLU B 353 LEU B 387 ARG B 394 SITE 2 AC2 9 PHE B 404 MET B 421 HIS B 524 LEU B 525 SITE 3 AC2 9 HOH B2060
CRYST1 54.820 63.620 74.720 90.00 98.34 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.018241 0.000000 0.002674 0.00000
SCALE2 0.000000 0.015718 0.000000 0.00000
SCALE3 0.000000 0.000000 0.013526 0.00000
MTRIX1 1 0.957290 0.009480 0.288970 -4.27827 1
MTRIX2 1 0.009430 -0.999950 0.001580 -0.19802 1
MTRIX3 1 0.288970 0.001210 -0.957340 29.09181 1